TP ICAP Midcap Initiates Coverage of SMAIO With a “Buy” Recommendation
June 08 2022 - 12:00PM
Business Wire
Regulatory News:
SMAIO (Software, Machines and
Adaptative Implants in Orthopaedics – Euronext
Growth Paris ISIN: FR0014005I80 / Ticker: ALSMA), a French player
specialized in complex spine surgery with a global offer comprising
software, adaptative implants and related services, today announced
that TP ICAP Midcap, a brokerage firm and investment bank
specializing in small and mid-caps, has initiated coverage of its
shares.
In its initiation study published on June 3, 2022, TP ICAP
Midcap began covering the stock with a “Buy” recommendation and
valued the company at EUR 6.3 per share*.
* This information does not constitute an offer to sell or
subscribe, or the solicitation of an order to buy or subscribe,
securities in France, Europe, the United States or any other
country. The provision of a financial analysis production and
dissemination service has been agreed between SMAIO and TP ICAP
Midcap.
Upcoming financial events:
- Shareholders’ AGM: June 20, 2022
- Publication of H1 2022 sales: July 12, 2022, after
market
About SMAIO
A precursor in the use of clinical data and imaging of the
spine, SMAIO designs global solutions for spine surgery
specialists. The Company has recognized expertise thanks to KEOPS,
its Big Data management software that has become a global reference
with more than 100,000 patient cases documented.
SMAIO offers spine surgeons a comprehensive platform, I-Kontrol,
incorporating planning, implants and related services, enabling
them to treat spinal pathologies in a safe, effective and lasting
way.
SMAIO is positioned at the forefront of innovation with the
ambition of providing surgeons with the first active robotic
solution enabling a high level of performance and repeatability to
be achieved.
Based in Lyon, France, SMAIO benefits from the skill and
expertise of more than 30 highly specialized staff.
For further information, please visit our website:
www.smaio.com
Listing market: Euronext Growth Paris ISIN:
FR0014005I80 Mnemonic: ALSMA
Disclaimer
This press release contains non-factual elements, including, but
not limited to, certain statements regarding future results and
other future events. These statements are based on the current
vision and assumptions of the management of the Company. They
incorporate known and unknown risks and uncertainties that could
result in significant differences in results, profitability and
expected events. In addition, SMAIO, its shareholders and its
affiliates, directors, officers, counsels and employees have not
verified the accuracy of, and make no representations or warranties
about, statistical information or forecast information contained
within this news release and that originates or is derived from
third party sources or industry publications; these statistical
data and forecast information are only used in this press release
for information purposes. Finally, this press release may be
drafted in French and in English. In the event of differences
between the two texts, the French version will prevail.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220608005852/en/
SMAIO Philippe Roussouly Chief Executive Officer Fabrice
Kilfiger Chief Financial Officer investors@smaio.com
NewCap Dusan Oresansky/Quentin Massé Investor Relations
smaio@newcap.eu Tel.: +33 (0)1 44 71 94 92
NewCap Nicolas Merigeau Media Relations smaio@newcap.eu
Tel.: +33 (0)1 44 71 94 98
SMAIO (EU:ALSMA)
Historical Stock Chart
From Jun 2024 to Jul 2024
SMAIO (EU:ALSMA)
Historical Stock Chart
From Jul 2023 to Jul 2024